查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1661011

2025 年至 2033 年人工胰臟設備系統市場報告（按設備類型、治療類型、最終用戶和地區）

Artificial Pancreas Device Systems Market Report by Device Type, Treatment Type, End-User, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 142 Pages | 商品交期: 2-3個工作天內

價格

2024 年全球人工胰臟裝置系統 (APDS) 市場規模達到 25.794 億美元。 展望未來， IMARC Group預計到 2033 年市場規模將達到 60.272 億美元，2025-2033 年期間的成長率 (CAGR) 為 9.9%。

APDS 是指閉迴路或自動化胰島素輸送系統，透過調節胰島素的產生來管理血糖水平。它由連續血糖監測儀 (CGM)、皮下胰島素輸注幫浦和連接監測儀和幫浦的控制器組成。它運行一個複雜的演算法，根據即時血糖讀數的評估來確定適當的胰島素水平和輸送時間。它主要用於最大限度地降低體內血糖水平劇烈波動的風險。

胰臟癌、胰臟炎和其他慢性疾病的發生率不斷上升是推動市場成長的關鍵因素之一。此外，由於年齡相關因素、缺乏運動和不健康的飲食習慣導致糖尿病和肥胖症的發生率不斷上升，也促使全球廣泛採用 APDS。對高效糖尿病監測和微創（MI）藥物輸送系統的需求不斷成長也促進了市場的成長。 APDS 自動監測血糖水平，並全天注射可控制劑量的胰島素。各種技術創新，包括開發與自動控制相結合的軟體為基礎的無線系統，進一步促進了市場的成長。此外，各國監管機構和政府都在大力投資研發（R&D），以改善全球醫療保健基礎設施。例如，美國食品藥物管理局（US FDA）正在批准越來越多的新產品和創新產品，這為該國市場創造了積極的前景。

本報告回答的關鍵問題：

  • 全球人工胰臟裝置系統市場迄今表現如何？
  • 主要的區域市場有哪些？
  • COVID-19 對全球人工胰臟設備系統市場有何影響？
  • 根據設備類型，市場如何分佈？
  • 根據治療類型，市場如何分類？
  • 根據最終用戶，市場分佈如何？
  • 該產業的價值鏈分為哪些階段？
  • 該行業的關鍵促進因素和挑戰是什麼？
  • 全球人工胰臟裝置系統市場的結構是怎樣的？
  • 產業的競爭程度如何？

目錄

第 1 章：前言

第 2 章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 次要來源
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球人工胰臟裝置系統市場

  • 市場概況
  • 市場表現
  • COVID-19 的影響
  • 市場預測

第6章：市場細分：依設備類型

  • 閾值暫停設備系統
    • 市場趨勢
    • 市場預測
  • 控制至射程系統
    • 市場趨勢
    • 市場預測
  • 控制至目標系統
    • 市場趨勢
    • 市場預測

第 7 章：市場區隔：依治療類型

  • 雙荷爾蒙
    • 市場趨勢
    • 市場預測
  • 僅使用胰島素
    • 市場趨勢
    • 市場預測
  • 混合
    • 市場趨勢
    • 市場預測

第 8 章：市場區隔：依最終用戶

  • 醫院
    • 市場趨勢
    • 市場預測
  • 醫療中心
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第9章：市場細分：依地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場趨勢
    • 市場區隔：依國家
    • 市場預測

第 10 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章：價格指標

第 14 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Beta Bionics Inc.
    • Bigfoot Biomedical Inc.
    • Dexcom Inc.
    • Inreda Diabetic BV
    • Insulet Corporation
    • Johnson & Johnson
    • Medtronic Inc.
    • F. Hoffmann-La Roche Ltd
    • Tandem Diabetes Care Inc.
Product Code: SR112025A1918

The global artificial pancreas device systems (APDS) market size reached USD 2,579.4 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 6,027.2 Million by 2033, exhibiting a growth rate (CAGR) of 9.9% during 2025-2033.

APDS refers to a closed-loop or automated insulin delivery system that manages blood glucose levels by regulating the production of insulin. It consists of a continuous glucose monitor (CGM), a subcutaneous insulin infusion pump and a controller that links the monitor with the pump. It runs a complex algorithm that determines the adequate levels of insulin and time of delivery based on the evaluation of real-time glucose readings. It is primarily used to minimize the risks of extreme fluctuations of glucose levels in the body.

The increasing prevalence of pancreatic cancer, pancreatitis and other chronic ailments is one of the key factors driving the growth of the market. Furthermore, the growing occurrence of diabetes and obesity, due to age-related factors, physical inactivity and unhealthy dietary patterns, is also contributing to the widespread adoption of APDS across the globe. The rising demand for efficient diabetes monitoring and minimally invasive (MI) drug delivery systems is also providing a boost to the market growth. APDS automatically monitors the glucose levels and administers doses of insulin throughout the day in controlled amounts. Various technological innovations, including the development of software-based wireless systems that are integrated with automated controls, are further contributing to the market growth. Moreover, regulatory bodies and governments of various nations are significantly investing in research and development (R&D) for the improvement of healthcare infrastructure across the globe. For instance, the Food and Drug Association (US FDA) in the United States is approving an increasing number of new and innovative products, which is creating a positive outlook for the market in the country.

Key Market Segmentation:

Breakup by Device Type:

  • Threshold Suspend Device Systems
  • Control-to-Range Systems
  • Control-to-Target Systems

Breakup by Treatment Type:

  • Bi-hormonal
  • Insulin Only
  • Hybrid

Breakup by End-User:

  • Hospitals
  • Medical Centres
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined with some of the key players being Beta Bionics Inc., Bigfoot Biomedical Inc., Dexcom Inc., Inreda Diabetic B.V., Insulet Corporation, Johnson & Johnson, Medtronic Inc., F. Hoffmann-La Roche Ltd, Tandem Diabetes Care Inc., etc.

Key Questions Answered in This Report:

  • How has the global artificial pancreas device systems market performed so far and how will it perform in the coming years?
  • What are the key regional markets?
  • What has been the impact of COVID-19 on the global artificial pancreas device systems market?
  • What is the breakup of the market based on the device type?
  • What is the breakup of the market based on the treatment type?
  • What is the breakup of the market based on the end-user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global artificial pancreas device systems market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Artificial Pancreas Device Systems Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Device Type

  • 6.1 Threshold Suspend Device Systems
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Control-to-Range Systems
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Control-to-Target Systems
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Treatment Type

  • 7.1 Bi-hormonal
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Insulin Only
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Hybrid
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by End-User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Medical Centres
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Indicators

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Beta Bionics Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Bigfoot Biomedical Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Dexcom Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Inreda Diabetic B.V.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 Insulet Corporation
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Johnson & Johnson
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Medtronic Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 F. Hoffmann-La Roche Ltd
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
    • 14.3.9 Tandem Diabetes Care Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials

List of Figures

  • Figure 1: Global: Artificial Pancreas Device Systems Market: Major Drivers and Challenges
  • Figure 2: Global: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019-2024
  • Figure 3: Global: Artificial Pancreas Device Systems Market: Breakup by Device Type (in %), 2024
  • Figure 4: Global: Artificial Pancreas Device Systems Market: Breakup by Treatment Type (in %), 2024
  • Figure 5: Global: Artificial Pancreas Device Systems Market: Breakup by End-User (in %), 2024
  • Figure 6: Global: Artificial Pancreas Device Systems Market: Breakup by Region (in %), 2024
  • Figure 7: Global: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 8: Global: Artificial Pancreas Device Systems (Threshold Suspend Device Systems) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Artificial Pancreas Device Systems (Threshold Suspend Device Systems) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Artificial Pancreas Device Systems (Control-to-Range Systems) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Artificial Pancreas Device Systems (Control-to-Range Systems) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Artificial Pancreas Device Systems (Control-to-Target Systems) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Artificial Pancreas Device Systems (Control-to-Target Systems) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Artificial Pancreas Device Systems (Bi-hormonal) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Artificial Pancreas Device Systems (Bi-hormonal) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Artificial Pancreas Device Systems (Insulin Only) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Artificial Pancreas Device Systems (Insulin Only) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Artificial Pancreas Device Systems (Hybrid) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Artificial Pancreas Device Systems (Hybrid) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Artificial Pancreas Device Systems (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Artificial Pancreas Device Systems (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Artificial Pancreas Device Systems (Medical Centres) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Artificial Pancreas Device Systems (Medical Centres) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Artificial Pancreas Device Systems (Other End-Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Artificial Pancreas Device Systems (Other End-Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: North America: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: North America: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: United States: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: United States: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Canada: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Canada: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Asia Pacific: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Asia Pacific: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: China: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: China: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Japan: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Japan: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: India: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: India: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: South Korea: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: South Korea: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Australia: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Australia: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Indonesia: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Indonesia: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Others: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Others: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Europe: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Europe: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Germany: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Germany: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: France: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: France: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: United Kingdom: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: United Kingdom: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Italy: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Italy: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Spain: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Spain: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Russia: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Russia: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Others: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Others: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Latin America: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Latin America: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Brazil: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Brazil: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Mexico: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Mexico: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Others: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Others: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Middle East and Africa: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Middle East and Africa: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Global: Artificial Pancreas Device Systems Industry: SWOT Analysis
  • Figure 75: Global: Artificial Pancreas Device Systems Industry: Value Chain Analysis
  • Figure 76: Global: Artificial Pancreas Device Systems Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Artificial Pancreas Device Systems Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Artificial Pancreas Device Systems Market Forecast: Breakup by Device Type (in Million USD), 2025-2033
  • Table 3: Global: Artificial Pancreas Device Systems Market Forecast: Breakup by Treatment Type (in Million USD), 2025-2033
  • Table 4: Global: Artificial Pancreas Device Systems Market Forecast: Breakup by End-User (in Million USD), 2025-2033
  • Table 5: Global: Artificial Pancreas Device Systems Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Artificial Pancreas Device Systems Market: Competitive Structure
  • Table 7: Global: Artificial Pancreas Device Systems Market: Key Players